Sylvester Comprehensive Cancer Center, Division of Epidemiology & Population Health Sciences, Department of Public Health Sciences, University of Miami School of Medicine, Miami, FL, USA.
Department of Public Health Sciences, University of Miami School of Medicine, Miami, FL, USA.
Liver Int. 2020 May;40(5):1201-1210. doi: 10.1111/liv.14409. Epub 2020 Mar 8.
The incidence of hepatocellular carcinoma (HCC) has risen considerably in the US since 1980. The main causes include metabolic disorders (NAFLD, diabetes, obesity, metabolic syndrome), alcohol-related disease (ALD) and hepatitis C and B virus infections (HCV, HBV). Etiology-specific HCC incidence rates by detailed race-ethnicity are needed to improve HCC control and prevention efforts.
All HCC cases diagnosed in Florida during 2014-2015 were linked to statewide hospital discharge data to determine etiology. Age-specific and age-adjusted rates were used to assess the intersection between etiology and detailed racial-ethnicities, including White, African American, Afro-Caribbean, Asian, Cuban, Puerto Rican and Continental Hispanic (Mexican, South and Central American).
Of 3666 HCC cases, 2594 matched with discharge data. HCV was the leading cause of HCC among men and women (50% and 43% respectively), followed by metabolic disorders (25% and 37%) and ALD (16% and 9%). Puerto Rican and African American men had the highest HCV-HCC rates, 7.9 and 6.3 per 100 000 respectively. Age-specific rates for HCV-HCC peaked among baby boomers (those born in 1945-1965). Metabolic-HCC rates were highest among populations above age 70 and among Continental Hispanics. Afro-Caribbean men had high rates of HBV-HCC, whereas Puerto Rican men had high ALD-HCC.
HCC etiology is associated with specific race/ethnicity. While HCV-related HCC rates are projected to decrease soon, HCC will continue to affect Hispanics disproportionately, based on higher rates of metabolic-HCC (and ALD-HCC) among Continental Hispanics, who demographically represent 80% of all US Hispanics. Multifaceted approaches for HCC control and prevention are needed.
自 1980 年以来,美国的肝细胞癌(HCC)发病率显著上升。主要病因包括代谢紊乱(非酒精性脂肪性肝病、糖尿病、肥胖、代谢综合征)、酒精相关疾病(ALD)和丙型肝炎及乙型肝炎病毒感染(HCV、HBV)。需要根据详细的种族和族裔来确定病因特异性 HCC 发病率,以改善 HCC 的控制和预防工作。
将 2014 年至 2015 年期间在佛罗里达州诊断出的所有 HCC 病例与全州的医院出院数据相联系,以确定病因。使用年龄特异性和年龄调整后的发病率来评估病因与详细的种族和族裔之间的交叉情况,包括白人、非裔美国人、非裔加勒比人、亚洲人、古巴人、波多黎各人以及中美洲和南美洲裔(大陆西班牙裔)。
在 3666 例 HCC 病例中,有 2594 例与出院数据相匹配。HCV 是男性和女性 HCC 的主要病因(分别为 50%和 43%),其次是代谢紊乱(分别为 25%和 37%)和 ALD(分别为 16%和 9%)。波多黎各和非裔美国男性的 HCV-HCC 发病率最高,分别为每 10 万人 7.9 和 6.3。HCV-HCC 的年龄特异性发病率在婴儿潮一代(1945 年至 1965 年出生的人)中达到峰值。代谢性 HCC 发病率在 70 岁以上人群和中美洲裔中最高。非裔加勒比男性的 HBV-HCC 发病率较高,而波多黎各男性的 ALD-HCC 发病率较高。
HCC 的病因与特定的种族和族裔有关。虽然预计 HCV 相关 HCC 的发病率将很快下降,但鉴于中美洲裔的代谢性 HCC(和 ALD-HCC)发病率较高,HCC 将继续不成比例地影响西班牙裔人群,因为中美洲裔在所有美国西班牙裔中占 80%。需要采取多方面的方法来控制和预防 HCC。